AUTHORS

Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
Email Bruce Kamich

Recent Articles By The Author

Bed Bath & Beyond Could Rally Further Despite Short Sellers

I wouldn't recommend shorting the stock ahead of earnings on Thursday.

Constellation Brands Could Disappoint the Thirsty Bulls

Let's review the charts and indicators ahead of earnings.

As Toll Brothers Keeps Hammering Away, Its Technical Picture Strengthens

Let's check the charts as Toll Brothers gets upgraded to a Buy by TheStreet's quantitative service.

The Pepsi Challenge: How to Trade the Stock Into Earnings

A technical strategy update on PepsiCo ahead of earnings.

Weakness in Spice-Maker McCormick May Be a Buying Opportunity

If MKC holds its late September lows, it should be approached from the long side.

Take a Cautious Approach to Micron Right Now

Let's review the charts and indicators.

Where's the Stock Market Headed Into Year-End? A Technical Look and Strategy

In late August/early September the major indices were making medium-term tops.

Investors' Appetite for McDonald's Shares Seems to Be Waning

Make your shares of MCD 'to go' for the next several weeks.

Abbott Labs Stock Could Still Slip Lower

Let's review the charts and indicators.

Should Investors Feel Secure With ADT?

The price gap and subsequent action on ADT tells the real story.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight